ArticleOncoimmunology2016

Antibody targeting soluble NKG2D ligand sMIC refuels and invigorates the endogenous immune system to fight cancer.

Jennifer WuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.